Prospects of genetic research of mild cognitive impairment

Journal of Internal Medicine

Volumn 256, Issue 3, 2004, Pages 235-239

  Van Duijn, C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Genetics and dementia; Mild cognitive impairment

Indexed keywords

APOLIPOPROTEIN E;

AGING; ALLELE; ALZHEIMER DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; GENETICS; HETEROZYGOTE; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; PROGNOSIS;

EID: 4544322254     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2004.01366.x     Document Type: Conference Paper

References (33)

1. Honig LS, Mayeux R. Natural history of Alzheimer's disease. Aging 2001; 13: 171-82.
2. Roks G, van Duijn CM. Genetic epidemiology of Alzheimer's disease. In: Sham PM, ed. Analysis of Multifactorial Diseases. Oxford: Bios. 2000; 85-100.
3. Small SA, Stern Y, Tang M et al. Selective decline in memory function among healthy elderly. Neurology 1999; 52: 1392-6.
4. St George-Hyslop PH, Tanzi RE, Polinsky RJ et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 1987; 235: 885-90.
5. Tanzi RE, Gusella JF, Watkins PC et al. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 1987; 235: 880-4.
6. Goate A, Chartier-Harlin MC, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-6.
7. van Broeckhoven CL. Molecular genetics of Alzheimer disease: identification of genes and gene mutations. Eur Neurol 1995; 35: 8-19.
8. Schellenberg GD, Bird TD, Wijsman EM et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992; 258: 668-71.
9. St George-Hyslop P, Haines J, Rogaev E et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 1992; 2: 330-4.
10. Mullan M, Houlden H, Windelspecht M et al. A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nat Genet 1992; 2: 340-2.
11. van Broeckhoven C, Backhovens H, Cruts M et al. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet 1992; 2: 335-9.
12. Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754-60.
13. Levy-Lahad E, Wasco W, Poorkaj P et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973-7.
14. Rogaev EI, Sherrington R, Rogaeva EA et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995; 376: 775-8.
15. Slooter A, Breteler MMB, Ott A, van Broeckhoven C, van Duijn CM. APOE genotyping in differential diagnosis of Alzheimer's disease (Letter). Lancet 1996; 348: 334.
16. Almkvist O, Axelman K, Basun H et al. Clinical findings in non demented mutation carriers predisposed to Alzheimer's disease: a model of mild cognitive impairment. Acta Neurol Scan 2003; 179: 77-82.
17. Pericak-Vance MA, Bebout JL, Gaskell PC Jr et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991; 48: 1034-50.
18. Tol J, Roks G, Slooter AJ, van Duijn CM. Genetic and environmental factors in Ahheimer's disease. Rev Neurol (Paris) 1999; 155: S10-6.
19. Almkvist O, Axelman K, Basun H et al. Conversion from preclinical to clinical stage of Alzheimer's disease in carriers of the Swedish APP mutation. J Neural Transm 2002; 62: 117-25.
20. Cruts M, van Duijn CM, Backhovens H et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 1998; 7: 43-51.
21. Strittmatter WJ, Saunders AM, Schmechel D et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977-81.
22. Croes EA, Dermaut B, van der Cammen TJ et al. Genetic testing should not be advocated as a diagnostic tool in familial forms of dementia. Am J Hum Genet 2000; 67: 1033-5.
23. Cruts M, van Broeckhoven C. Molecular genetics of Alzheimer's disease. Ann Med 1998; 30: 560-5.
24. Holtzman NA, Marteau TM. Will genetics revolutionize medicine? N Engl J Med 2000; 343: 141-4.
25. Yang Q, Khoury MJ, Botto L, Friedman JM, Flanders WD. Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 2003; 72: 636-49.
26. Janssens AC, Pardo MC, Steyerberg EW, van Duijn CM. Revisiting the clinical validity of multiplex genetic testing in complex diseases. Am J Hum Genet 2004; 74: 585-8.
27. Tervo S, Kivipelto M, Hanninen T et al. Incidence and risk factors for mild cognitive impairment: a population based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 2004; 17: 196-203.
28. Lopez OL, Jagust WJ, Dulberg C et al. Risk factors for mild cognitive impairment in the cardiovascular health study cognition study: part 2. Arch Neurol 2003; 60: 1394-9.
29. Engelborghs S, Dermaut B, Goeman J et al. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. J Neurol Neurosurg Psychiatry 2003; 74: 1148-51.
30. Traykov L, Rigaud AS, Baudic S, Smagghe A, Boller F, Forette F. Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. J Neurol Sci 2002; 15: 203-4: 177-81.
31. Lautenschlager NT, Riemenschneider M, Drzezga A, Kurz AF. Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings. Dement Geriatr Cogn Disord 2001; 12: 379-86.
32. Batres-Faz D, Junque C, Lopez-Alomar A et al. Neuropsychological and genetic differences between age-associated memory impairment and mild cognitive impairment entities. J Am Geriatr Soc 2001; 49: 985-90.
33. de Leon MJ, Con vit A, Wolf OT et al. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci USA 2001; 98: 10966-71.